AR068536A1 - Vacuna antigripal inactivada - Google Patents

Vacuna antigripal inactivada

Info

Publication number
AR068536A1
AR068536A1 ARP080104130A ARP080104130A AR068536A1 AR 068536 A1 AR068536 A1 AR 068536A1 AR P080104130 A ARP080104130 A AR P080104130A AR P080104130 A ARP080104130 A AR P080104130A AR 068536 A1 AR068536 A1 AR 068536A1
Authority
AR
Argentina
Prior art keywords
inactivated
vaccine
influenza
virus
influenza virus
Prior art date
Application number
ARP080104130A
Other languages
English (en)
Spanish (es)
Inventor
Henrikus Lodewijk Glansbeek
Jacobus Gerardus Maria Heldens
Original Assignee
Nobilon Internat B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nobilon Internat B V filed Critical Nobilon Internat B V
Publication of AR068536A1 publication Critical patent/AR068536A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
ARP080104130A 2007-09-24 2008-09-24 Vacuna antigripal inactivada AR068536A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97456807P 2007-09-24 2007-09-24
EP07117050 2007-09-24

Publications (1)

Publication Number Publication Date
AR068536A1 true AR068536A1 (es) 2009-11-18

Family

ID=39590199

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080104130A AR068536A1 (es) 2007-09-24 2008-09-24 Vacuna antigripal inactivada

Country Status (6)

Country Link
EP (1) EP2195020A1 (pt)
CN (1) CN101808659A (pt)
AR (1) AR068536A1 (pt)
BR (1) BRPI0817230A2 (pt)
TW (1) TW200927928A (pt)
WO (1) WO2009040343A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9278999B2 (en) 2012-01-27 2016-03-08 Newport Laboratories Influenza C virus and vaccine
CA2954740C (en) 2014-07-11 2022-10-18 National Research Council Of Canada Sulfated-glycolipids as adjuvants for vaccines
CN104792985A (zh) * 2015-04-21 2015-07-22 乾元浩生物股份有限公司 定性定量分析禽用禽流感病毒抗原有效成分的方法
EP3684406A4 (en) * 2017-09-07 2021-08-11 Hawaii Biotech, Inc. FILOVIRUS VACCINES AND METHOD OF USE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1104767A1 (en) * 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups
NZ594482A (en) * 2005-11-04 2012-11-30 Novartis Vaccines & Diagnostic Influenza vaccines with reduced amount of oil-in-water emulsion as adjuvant

Also Published As

Publication number Publication date
CN101808659A (zh) 2010-08-18
WO2009040343A1 (en) 2009-04-02
BRPI0817230A2 (pt) 2017-06-06
EP2195020A1 (en) 2010-06-16
TW200927928A (en) 2009-07-01

Similar Documents

Publication Publication Date Title
BR112013022397A2 (pt) vacinas combinadas com doses menores de antígeno e/ou adjuvante
BR112018012873A2 (pt) vacina de vírus zika
BR112018008102A2 (pt) vacina de vírus sincicial respiratório
CO2017011245A2 (es) Conjugados proteína-polisacárido de estreptococo grupo b, métodos para producir conjugados, composiciones inmunógenas que comprenden conjugados y sus usos
CL2016003048A1 (es) Analogos de panonina minimas sintesis y uso de los mismos.
BR112018008090A2 (pt) vacina de vírus do herpes simplex.
BR112018008078A2 (pt) vacina de vírus influenza de amplo espectro
BR112013029834A8 (pt) vacinas individualizadas para câncer
BR112012004698A2 (pt) métodos de redução de atividade virucida em composições de pcv-2 e composições de pcv-2 com uma imonugenicidade aprimorada.
BR112012020839A2 (pt) vacinas para uso na profilaxe e tratamento de doença de vírus da influenza
BRPI0918806A2 (pt) composição compreendendo quitosana para administração ocular de vaninas em aves
AR073959A1 (es) Vacuna de combinacion con tos ferina acelular y metodo para su elaboracion
BR112015018270A2 (pt) composições que compreendem 15-ohepa e métodos de uso das mesmas
BR112018010503A2 (pt) ovo de ave, método para replicar um vírus, vírus, método para produzir uma composição de vacina, composição de vacina, ave transgênica, e método para produzir uma ave
UY33297A (es) Composiciones farmaceuticas que comprenden un polipéptido que comprende al menos un motivo cxxc y antígenos heterólogos y usos de las mismas
AR068536A1 (es) Vacuna antigripal inactivada
PE20151588A1 (es) Vacuna contra el virus del dengue
BR112015005056A2 (pt) vacinas de combinação com sorogrupo b meningococcus e d/t/p
BR112012030659B8 (pt) Parvovírus vivo atenuado, vacinas que o compreendem e método para a fabricação das referidas vacinas
CO2017007057A2 (es) Vacuna contra la fiebre aftosa
BR112016030294A8 (pt) cepa de bactérias probióticas de lactobacillus e uma vacina de aves domésticas, composição, ovo de aves domésticas embrionado, kit, e, método de vacinação in ovo de aves domésticas
BR112019009131A2 (pt) vacina contra o parvovírus suíno, o vírus da síndrome respiratória e reprodutiva dos suínos e métodos de produção das mesmas
CU24579B1 (es) Proceso de preparación de una vacuna tetravalente atenuada contra el virus del dengue
BR112017004746A2 (pt) métodos para preparação de virossomas adjuvados, para otimizar a proporção adjuvante/antígeno de uma vacina à base de virossoma e para imunizar um indivíduo contra uma doença, virossoma adjuvado, composição farmacêutica, e, composição imunogênica.
BR112013006515B1 (pt) vacina de combinação, e, método para a fabricação de uma vacina de combinação

Legal Events

Date Code Title Description
FB Suspension of granting procedure